Please login or register first to view this content.
Dermatological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Shift Seen to Newer Agents to Treat Psoriasis
Newly Diagnosed Lupus Erythematosus Could Potentially Be Drug Induced
Winlevi Cream Approved for Acne Vulgaris
Tapinarof Cream Looks Promising for Plaque Psoriasis
FDA: Small Risk of Skin Cancer With Hydrochlorothiazide Use
Delgocitinib Cream Gets Fast Track Status for Chronic Hand Eczema
Stelara Approved for Pediatric Plaque Psoriasis
Head Lice Treatment Xeglyze Gets FDA Approval
Bimekizumab Bests Secukinumab in Plaque Psoriasis Trial
Wynzora Cream Approved for Plaque Psoriasis
Second Trial Evaluating Upadacitinib in Atopic Dermatitis Meets End Point
Mirikizumab Tops Secukinumab in Plaque Psoriasis Trial
Roflumilast Cream Promising for Chronic Plaque Psoriasis
FDA to Review Tralokinumab for Moderate to Severe Atopic Dermatitis
Imsidolimab Gets Orphan Drug Designation for Generalized Pustular Psoriasis
Investigational Oral JAK Inhibitor Gets Breakthrough Tx Status for Alopecia Areata
Mylan Recalls One Lot of Daptomycin for Injection
FDA Approves Qwo to Treat Moderate to Severe Cellulite
